Skip to main content

Global Antibody-drug Conjugates Sales Market 2017 (Seattle Genetics technology, ImmunoGen technology and Immunomedics technology) Analysis,Opportunities and Forecasts to 2022

Press Release   •   Aug 22, 2017 04:24 EDT

In this report, the Global Antibody-drug Conjugates Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Click Here To Get Request Sample: http://globalqyresearch.com/download-sample/259125 

Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Antibody-drug Conjugates for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Antibody-drug Conjugates market competition by top manufacturers/players, with Antibody-drug Conjugates sales volume, Price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
F. Hoffmann-La Roche
Seattle Genetics
Takeda Pharmaceuticals
AbbVie
AbGenomics
ADC Therapeutics
Agensys
ALMAC Group
Ambrx
Astellas Pharma

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into
Seattle Genetics technology
ImmunoGen technology
Immunomedics technology

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody-drug Conjugates for each application, including
IgG1 antibodies
HER2 antibodies

Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

Global Antibody-drug Conjugates Sales Market Report 2017
1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Classification of Antibody-drug Conjugates by Product Category
1.2.1 Global Antibody-drug Conjugates Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Antibody-drug Conjugates Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Seattle Genetics technology
1.2.4 ImmunoGen technology
1.2.5 Immunomedics technology
1.3 Global Antibody-drug Conjugates Market by Application/End Users
1.3.1 Global Antibody-drug Conjugates Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 IgG1 antibodies
1.3.3 HER2 antibodies
1.4 Global Antibody-drug Conjugates Market by Region
1.4.1 Global Antibody-drug Conjugates Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.3 China Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.4 Europe Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.5 Japan Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.6 Southeast Asia Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.7 India Antibody-drug Conjugates Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Antibody-drug Conjugates (2012-2022)
1.5.1 Global Antibody-drug Conjugates Sales and Growth Rate (2012-2022)
1.5.2 Global Antibody-drug Conjugates Revenue and Growth Rate (2012-2022)

2 Global Antibody-drug Conjugates Competition by Players/Suppliers, Type and Application
2.1 Global Antibody-drug Conjugates Market Competition by Players/Suppliers
2.1.1 Global Antibody-drug Conjugates Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Antibody-drug Conjugates Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Antibody-drug Conjugates (Volume and Value) by Type
2.2.1 Global Antibody-drug Conjugates Sales and Market Share by Type (2012-2017)
2.2.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2012-2017)
2.3 Global Antibody-drug Conjugates (Volume and Value) by Region
2.3.1 Global Antibody-drug Conjugates Sales and Market Share by Region (2012-2017)
2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Region (2012-2017)
2.4 Global Antibody-drug Conjugates (Volume) by Application

3 United States Antibody-drug Conjugates (Volume, Value and Sales Price)
3.1 United States Antibody-drug Conjugates Sales and Value (2012-2017)
3.1.1 United States Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
3.1.2 United States Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
3.1.3 United States Antibody-drug Conjugates Sales Price Trend (2012-2017)
3.2 United States Antibody-drug Conjugates Sales Volume and Market Share by Players
3.3 United States Antibody-drug Conjugates Sales Volume and Market Share by Type
3.4 United States Antibody-drug Conjugates Sales Volume and Market Share by Application

4 China Antibody-drug Conjugates (Volume, Value and Sales Price)
4.1 China Antibody-drug Conjugates Sales and Value (2012-2017)
4.1.1 China Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
4.1.2 China Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
4.1.3 China Antibody-drug Conjugates Sales Price Trend (2012-2017)
4.2 China Antibody-drug Conjugates Sales Volume and Market Share by Players
4.3 China Antibody-drug Conjugates Sales Volume and Market Share by Type
4.4 China Antibody-drug Conjugates Sales Volume and Market Share by Application

5 Europe Antibody-drug Conjugates (Volume, Value and Sales Price)
5.1 Europe Antibody-drug Conjugates Sales and Value (2012-2017)
5.1.1 Europe Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
5.1.2 Europe Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
5.1.3 Europe Antibody-drug Conjugates Sales Price Trend (2012-2017)
5.2 Europe Antibody-drug Conjugates Sales Volume and Market Share by Players
5.3 Europe Antibody-drug Conjugates Sales Volume and Market Share by Type
5.4 Europe Antibody-drug Conjugates Sales Volume and Market Share by Application

6 Japan Antibody-drug Conjugates (Volume, Value and Sales Price)
6.1 Japan Antibody-drug Conjugates Sales and Value (2012-2017)
6.1.1 Japan Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
6.1.2 Japan Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
6.1.3 Japan Antibody-drug Conjugates Sales Price Trend (2012-2017)
6.2 Japan Antibody-drug Conjugates Sales Volume and Market Share by Players
6.3 Japan Antibody-drug Conjugates Sales Volume and Market Share by Type
6.4 Japan Antibody-drug Conjugates Sales Volume and Market Share by Application

7 Southeast Asia Antibody-drug Conjugates (Volume, Value and Sales Price)
7.1 Southeast Asia Antibody-drug Conjugates Sales and Value (2012-2017)
7.1.1 Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Antibody-drug Conjugates Sales Price Trend (2012-2017)
7.2 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Players
7.3 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Type
7.4 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Application

8 India Antibody-drug Conjugates (Volume, Value and Sales Price)
8.1 India Antibody-drug Conjugates Sales and Value (2012-2017)
8.1.1 India Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
8.1.2 India Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
8.1.3 India Antibody-drug Conjugates Sales Price Trend (2012-2017)
8.2 India Antibody-drug Conjugates Sales Volume and Market Share by Players
8.3 India Antibody-drug Conjugates Sales Volume and Market Share by Type
8.4 India Antibody-drug Conjugates Sales Volume and Market Share by Application

9 Global Antibody-drug Conjugates Players/Suppliers Profiles and Sales Data
9.1 F. Hoffmann-La Roche
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antibody-drug Conjugates Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 F. Hoffmann-La Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Seattle Genetics
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Antibody-drug Conjugates Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Takeda Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Antibody-drug Conjugates Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Takeda Pharmaceuticals Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 AbbVie
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Antibody-drug Conjugates Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 AbbVie Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 AbGenomics
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Antibody-drug Conjugates Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 AbGenomics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 ADC Therapeutics
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Antibody-drug Conjugates Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 ADC Therapeutics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Agensys
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Antibody-drug Conjugates Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Agensys Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 ALMAC Group
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Antibody-drug Conjugates Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 ALMAC Group Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Ambrx
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Antibody-drug Conjugates Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Ambrx Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Astellas Pharma
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Antibody-drug Conjugates Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Astellas Pharma Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Antibody-drug Conjugates Maufacturing Cost Analysis
10.1 Antibody-drug Conjugates Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antibody-drug Conjugates
10.3 Manufacturing Process Analysis of Antibody-drug Conjugates

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antibody-drug Conjugates Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antibody-drug Conjugates Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Antibody-drug Conjugates Market Forecast (2017-2022)
14.1 Global Antibody-drug Conjugates Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Antibody-drug Conjugates Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Antibody-drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Antibody-drug Conjugates Price and Trend Forecast (2017-2022)
14.2 Global Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Antibody-drug Conjugates Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Antibody-drug Conjugates Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Antibody-drug Conjugates Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Antibody-drug Conjugates Sales Forecast by Type (2017-2022)
14.3.2 Global Antibody-drug Conjugates Revenue Forecast by Type (2017-2022)
14.3.3 Global Antibody-drug Conjugates Price Forecast by Type (2017-2022)
14.4 Global Antibody-drug Conjugates Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/259125

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Browse Our Pharma Blog:http://pharmainvestmentnews.com/

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 3239 2407

Comments (0)

Add comment

Comment